Sclerostin inhibits osteoblast differentiation without affecting BMP2/SMAD1/5 or Wnt3a/β-catenin signaling but through activation of platelet-derived growth factor receptor signaling in vitro
Thouverey, Cyril, Caverzasio, JosephVolume:
4
Language:
english
Journal:
BoneKEy Reports
DOI:
10.1038/bonekey.2015.126
Date:
November, 2015
File:
PDF, 1.27 MB
english, 2015